const addChunk = (chunk) = {
有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
，更多细节参见safew官方版本下载
I submitted a review request with a brief clarification. Two hours later, an email arrived: the domain was cleared. The red banner vanished instantly.
The customer support resources located directly within